Elevation of B-type natriuretic peptide is a sensitive marker of left ventricular diastolic dysfunction in patients with maintenance haemodialysis

References

• Ahmed A, Rich MW, Sanders PW, Perry GJ, Bakris GL, Zile MR, Love TE, Aban IB, Shlipak MG. (2007). Chronic kidney disease associated mortality in diastolic versus systolic heart failure: a propensity matched study. Am J Cardiol 99:393–8.
   PubMed Web of Science ®Google Scholar
• Bertinchant JP. (2004). Brain natriuretic peptide (BNP) and N-terminal-pro BNP in chronic haemodialysed renal failure. Arch Mal Coeur Vaiss 97:881–8.
   PubMedGoogle Scholar
• Bossola M, Tazza L, Vulpio C, Luciani G. (2008). Is regression of left ventricular hypertrophy in maintenance hemodialysis patients possible. Semin Dial 21:422–30.
   PubMedGoogle Scholar
• Collins AJ. (2003). Cardiovascular mortality in end-stage renal disease. Am J Med Sci 325:163–7.
   PubMed Web of Science ®Google Scholar
• de Sa DD, Chen HH. (2008). The role of natriuretic peptides in heart failure. Curr Cardiol Rep 10:182–9.
   PubMedGoogle Scholar
• Devereux RB, Reichek N. (1977). Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 55:613–18.
   PubMed Web of Science ®Google Scholar
• Foley RN, Parfrey PS, Kent GM, Harnett JD, Murray DC, Barre PE. (2000). Serial change in echocardiographic parameters and cardiac failure in end-stage renal disease. J Am Soc Nephrol 11:912–16.
   PubMed Web of Science ®Google Scholar
• Haapio M, Ronco C. (2008). BNP and a renal patient: emphasis on the unique characteristics of B-type natriuretic peptide in end-stage kidney disease. Contrib Nephrol 161:68–75.
   PubMedGoogle Scholar
• Kasner M, Westermann D, Steendijk P, Gaub R, Wilkenshoff U, Weitmann K, Hoffmann W, Poller W, Schultheiss HP, Pauschinger M, Tschöpe C. (2007). Utility of Doppler echocardiography and tissue Doppler imaging in the estimation of diastolic function in heart failure with normal ejection fraction: a comparative Doppler-conductance catheterization study. Circulation 116:637–47.
   PubMed Web of Science ®Google Scholar
• Khouri SJ, Maly GT, Suh DD, Walsh TE. (2004). A practical approach to the echocardiographic evaluation of diastolic function. J Am Soc Echocardiogr 17:290–7.
   PubMed Web of Science ®Google Scholar
• Kindermann M, Reil JC, Pieske B, van VDJ, Böhm M. (2008). Heart failure with normal left ventricular ejection fraction: what is the evidence? Trends Cardiovasc Med 18:280–92.
   PubMedGoogle Scholar
• Komaba H, Igaki N, Goto S, Yokota K, Takemoto T, Hirosue Y, Goto T. (2007). Adiponectin is associated with brain natriuretic peptide and left ventricular hypertrophy in hemodialysis patients with type 2 diabetes mellitus. Nephron Clin Pract 107:c103–8.
   PubMedGoogle Scholar
• Lubien E, DeMaria A KP, Clopton P, Koon J, Kazanegra R, Gardetto N, Wanner E, Maisel AS. (2002). Utility of B-natriuretic peptide in detecting diastolic dysfunction: comparison with Doppler velocity recordings. Circulation 105:595–601.
   PubMed Web of Science ®Google Scholar
• Mallamaci F, Zoccali C, Tripepi G, Benedetto FA, Parlongo S, Cataliotti A, Cutrupi S, Giacone G, Bellanuova I, Stancanelli B, Malatino LS. (2001). Diagnostic potential of cardiac natriuretic peptides in dialysis patients. Kidney Int 59:1559–66.
   PubMed Web of Science ®Google Scholar
• Matayoshi T, Kato T, Nakahama H, Nakata H, Yoshihara F, Kamide K, Horio T, Nakamura S, Kawano Y. (2008). Brain natriuretic peptide in hemodialysis patients: predictive value for hemodynamic change during hemodialysis and cardiac function. Am J Nephrol 28:122–7.
   PubMedGoogle Scholar
• Meguid ENA, Bello AK. (2005). Chronic kidney disease: the global challenge. Lancet 365:331–40.
   PubMed Web of Science ®Google Scholar
• Nagueh SF, Middleton KJ, Kopelen HA, Zoghbi WA, Quiñones MA. (1997). Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J Am Coll Cardiol 30:1527–33.
   Google Scholar
• Nitta K, Kawashima A, Yumura W, Naruse M, Oba T, Kabaya T, Nihei H. (1998). Plasma concentration of brain natriuretic peptide as an indicator of cardiac ventricular function in patients on hemodialysis. Am J Nephrol 18:411–15.
   PubMedGoogle Scholar
• Otterstad JE, Froeland G, St JSM, Holme I. (1997). Accuracy and reproducibility of biplane two-dimensional echocardiographic measurements of left ventricular dimensions and function. Eur Heart J 18:507–13.
   PubMed Web of Science ®Google Scholar
• Potter LR, Yoder AR, Flora DR, Antos LK, Dickey DM. (2009). Natriuretic peptides: their structures, receptors, physiologic functions and therapeutic applications. Handb Exp Pharmacol 191:341–66.
   PubMedGoogle Scholar
• Pozzoni P, Del VL, Pontoriero G, Di FS, Locatelli F. (2004). Long-term outcome in hemodialysis: morbidity and mortality. J Nephrol 17:s87–s95
   PubMed Web of Science ®Google Scholar
• Racek J, Kralova H, Trefil L, Rajdl D, Eiselt J. (2006). Brain natriuretic peptide and N-terminal proBNP in chronic haemodialysis patients. Nephron Clin Pract 103:c162–72.
   PubMedGoogle Scholar
• Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, Gutgesell H, Reichek N, Sahn D, Schnittger I. (1989). Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 2:358–67.
   PubMed Web of Science ®Google Scholar
• Thomas JT, Kelly RF, Thomas SJ, Stamos TD, Albasha K, Parrillo JE, Calvin JE. (2002). Utility of history, physical examination, electrocardiogram, and chest radiograph for differentiating normal from decreased systolic function in patients with heart failure. Am J Med 112:437–45.
   PubMedGoogle Scholar
• Troughton RW, Richards AM. (2009). B-type natriuretic peptides and echocardiographic measures of cardiac structure and function. JACC Cardiovasc Imaging 2:216–25.
   PubMed Web of Science ®Google Scholar
• Zeng C, Wei T, Jin L, Wang L. (2006). Value of B-type natriuretic peptide in diagnosing left ventricular dysfunction in dialysis-dependent patients. Intern Med J 36:552–7.
   PubMedGoogle Scholar